HNST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HNST is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is near short-term resistance, earnings are coming up soon, fundamentals are still weak, and analysts have trimmed price targets even while keeping Buy/Outperform ratings. If the user is impatient and wants to buy now rather than wait for a better entry, this is still not an ideal long-term purchase today; hold off unless earnings and execution clearly improve.
HNST is trading pre-market at 3.51, just above the pivot level of 3.453 and below the first resistance at 3.6. MACD histogram is slightly positive at 0.00402 but contracting, which suggests momentum is fading rather than strengthening. RSI_6 is 60.089, neutral to mildly bullish, and moving averages are converging, indicating a sideways-to-slightly constructive trend rather than a clear breakout setup. The short-term pattern estimate points to modest upside, but not enough to justify a strong buy for a beginner long-term investor at this price.
["Options positioning is strongly call-skewed, suggesting traders are leaning bullish.", "Price is holding above the pivot area, with a mild short-term upward bias.", "Earnings are scheduled soon, which could create a catalyst if results improve.", "Analysts still broadly maintain Buy/Outperform-type ratings despite reduced price targets."]
["No recent news in the past week, so there is no fresh catalyst from headlines.", "Revenue in Q4 2025 fell 11.82% year over year, showing weak growth.", "Gross margin dropped sharply to 15.73%, indicating significant profitability pressure.", "Net loss widened materially despite EPS improvement from a loss base.", "Analyst price targets were lowered by multiple firms.", "Insiders have been selling, with selling up 106.76% over the last month.", "Earnings are due on 2026-05-06 after hours, so uncertainty is elevated.", "The stock is only slightly above support and below clear breakout resistance."]
In Q4 2025, Honest Company reported revenue of $88.04 million, down 11.82% year over year, which signals declining top-line momentum. Gross margin fell to 15.73%, down 59.49% year over year, showing meaningful pressure on product economics. Net income was -$23.57 million and EPS was -$0.23, both still negative, although the year-over-year changes reflect smaller losses relative to the prior comparison base. Overall, the latest quarter was weak operationally, with the main concern being shrinking revenue and margin compression.
Analyst sentiment is still constructive but less optimistic than before. Alliance Global and B. Riley both kept Buy ratings but lowered price targets to $3.50 from $4 after the Q4 report, while Northland lowered its target to $5 from $6 and kept an Outperform rating. The common theme is that Wall Street sees long-term potential, but expects several more quarters of consistent execution before re-rating the stock. Pros: analysts still like the story and maintain positive ratings. Cons: targets are being cut, results were slightly below Street expectations, and the near-term path to revaluation looks slow.
